









Markets
/
Stocks
/
nasdaq-aray
/

Accuray Inc

ARAY

0.620USD

+0.020+3.32%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

70.27MMarket Cap

LossP/E TTM



Accuray Inc

0.620

+0.020+3.32%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Accuray Inc

Currency: USD Updated: 2026-02-06

Key Insights

Accuray Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 74 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 2.52.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Accuray Inc's Score

Industry at a Glance

Industry Ranking

74 / 205

Overall Ranking

204 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Accuray Inc Highlights

StrengthsRisks

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.

Overvalued

The company’s latest PE is -2.09, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 79.19M shares, decreasing 0.02% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 10.25K shares of this stock.

Analyst Rating

Based on 2 analysts

Strong Buy

Current Rating

2.525

Target Price

+320.76%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Accuray Inc is 6.85, ranking 125 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 102.24M, representing a year-over-year decrease of 11.99%, while its net profit experienced a year-over-year decrease of 642.77%.

Score

Industry at a Glance

Previous score

6.85

Change



Financials

5.91

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.01

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.70

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.48

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.15

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Accuray Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Accuray Inc is 6.01, ranking 175 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -2.09, which is -10269.94% below the recent high of 212.37 and -5623.06% above the recent low of -119.51.

Score

Industry at a Glance

Previous score

6.01

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 74/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Accuray Inc is 10.00, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 3.88, with a high of 4.00 and a low of 3.75.

Score

Industry at a Glance

Previous score

10.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 2 analysts

Strong Buy

Current Rating

2.525

Target Price

+320.76%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Accuray Inc

ARAY

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Accuray Inc is 6.49, ranking 140 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 0.84 and the support level at 0.47, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.29

Change

0.2

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(1)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.029

Sell

RSI(14)

24.317

Sell

STOCH(KDJ)(9,3,3)

23.318

Neutral

ATR(14)

0.064

High Vlolatility

CCI(14)

-210.094

Oversold

Williams %R

75.000

Sell

TRIX(12,20)

-0.759

Sell

StochRSI(14)

22.139

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

0.706

Sell

MA10

0.756

Sell

MA20

0.800

Sell

MA50

0.890

Sell

MA100

1.188

Sell

MA200

1.317

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Accuray Inc is 7.00, ranking 80 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 76.52%, representing a quarter-over-quarter decrease of 0.79%. The largest institutional shareholder is The Vanguard, holding a total of 5.82M shares, representing 5.13% of shares outstanding, with 0.07% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

TCW Asset Management Company LLC

11.91M

BlackRock Institutional Trust Company, N.A.

7.09M

-1.92%

The Vanguard Group, Inc.

Star Investors

5.48M

+1.98%

Aevum Fondation de Prévoyance

5.47M

+1.36%

Neuberger Berman, LLC

5.28M

+0.79%

Heartland Advisors, Inc.

5.00M

-1.23%

Armistice Capital LLC

3.32M

+2.72%

Geode Capital Management, L.L.C.

2.49M

+2.84%

Renaissance Technologies LLC

Star Investors

2.48M

-4.61%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Accuray Inc is 2.65, ranking 149 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.19. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.